Synova Healthcare Group, Inc.Purchase Agreement • September 20th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 20th, 2007 Company Industry JurisdictionThis letter is to evidence certain consents, waivers, confirmations and amendments that relate to the following documents: (i) that certain Securities Purchase Agreement dated January 12, 2007 (the “Purchase Agreement”), among Synova Healthcare Group, Inc. (the “Company”), and each of the purchasers (collectively, the “Purchasers”) of the Company’s 6.5% Senior Convertible Promissory Notes due January 12, 2012 (the “Senior Notes”) and related common stock purchase warrants (collectively, the “Warrants”); (ii) that certain Registration Rights Agreement dated January 12, 2007, by and among the Company and certain of the Purchasers signatory thereto (the “Registration Rights Agreement”); (iii) that certain Guarantee Agreement dated January 12, 2007 (the “Guarantee Agreement”), among Synova Healthcare, Inc., Synova Pre-Natal Healthcare, Inc. and Allendale Pharmaceuticals, Inc. (collectively, the “Guarantors”), the Company, and each of the Purchasers, with respect to the Senior Notes; and (i
Synova Healthcare Group, Inc.Purchase Agreement • September 20th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 20th, 2007 Company IndustryThis letter is to evidence certain consents, waivers, confirmations and amendments that relate to the following documents: (i) that certain Securities Purchase Agreement dated January 12, 2007 (the “Purchase Agreement”), among Synova Healthcare Group, Inc. (the “Company”), and each of the purchasers (collectively, the “Purchasers”) of the Company’s 6.5% Senior Convertible Promissory Notes due January 12, 2012 (the “Senior Notes”) and related common stock purchase warrants (collectively, the “Warrants”); (ii) that certain Registration Rights Agreement dated January 12, 2007, by and among the Company and certain of the Purchasers signatory thereto (the “Registration Rights Agreement”); (iii) that certain Guarantee Agreement dated January 12, 2007 (the “Guarantee Agreement”), among Synova Healthcare, Inc., Synova Pre-Natal Healthcare, Inc. and Allendale Pharmaceuticals, Inc. (collectively, the “Guarantors”), the Company, and each of the Purchasers, with respect to the Senior Notes; and (i
Synova Healthcare Group, Inc.Purchase Agreement • September 20th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 20th, 2007 Company Industry JurisdictionThis letter is to evidence certain consents, waivers, confirmations and amendments that relate to the following documents: (i) that certain Securities Purchase Agreement dated January 12, 2007 (the “Purchase Agreement”), among Synova Healthcare Group, Inc. (the “Company”), and each of the purchasers (collectively, the “Purchasers”) of the Company’s 6.5% Senior Convertible Promissory Notes due January 12, 2012 (the “Senior Notes”) and related common stock purchase warrants (collectively, the “Warrants”); (ii) that certain Registration Rights Agreement dated January 12, 2007, by and among the Company and certain of the Purchasers signatory thereto (the “Registration Rights Agreement”); (iii) that certain Guarantee Agreement dated January 12, 2007 (the “Guarantee Agreement”), among Synova Healthcare, Inc., Synova Pre-Natal Healthcare, Inc. and Allendale Pharmaceuticals, Inc. (collectively, the “Guarantors”), the Company, and each of the Purchasers, with respect to the Senior Notes; and (i